Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Curr Pharm Des. 2014;20(33):5287–5297. doi: 10.2174/1381612820666140128213117

Figure 1.

Figure 1

Important differentially expressed miRNAs in GI malignancies and GI tract-associated organs. These include cancers from esophagus, stomach liver, pancreas, colon, and gall bladder. Upregulated miRNAs are shown in red color whereas the down regulated miRNAs are shown in black color.